Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

Document and Entity Information - shares
3 Months Ended
Sep. 30, 2019
Nov. 08, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name RELMADA THERAPEUTICS, INC.  
Entity Central Index Key 0001553643  
Amendment Flag false  
Current Fiscal Year End Date --06-30  
Document Type 10-Q  
Document Period End Date Sep. 30, 2019  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2020  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   10,275,339
Entity File Number 000-55347  
Entity Interactive Data Current Yes  
Entity Incorporation State Country Code NV